Pain Relief Extra Strength Capsule, Liquid Filled
NDC Package 53345-019-01
Package Information
Pain Relief Extra Strength (acetaminophen) capsules is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Humanwell Puracap Pharmaceutical (wuhan), Ltd., this product is identified by NDC 53345-019 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 198439 - acetaminophen 500 MG Oral Capsule
- RxCUI: 198439 - APAP 500 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53345 - Humanwell Puracap Pharmaceutical (wuhan), Ltd.
- 53345-019 - Pain Relief Extra Strength
- 53345-019-01 - 1 BAG in 1 BOX / 3000 CAPSULE, LIQUID FILLED in 1 BAG
- 53345-019 - Pain Relief Extra Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (53345-019). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53345-019-01 identifies a specific commercial package of 1 bag in 1 box / 3000 capsule, liquid filled in 1 bag of Pain Relief Extra Strength, a human over the counter drug labeled by Humanwell Puracap Pharmaceutical (wuhan), Ltd.. This capsule, liquid filled is formulated for oral use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Humanwell Puracap Pharmaceutical (wuhan), Ltd. on January 06, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Humanwell Puracap Pharmaceutical (wuhan), Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53345001901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.